2018
DOI: 10.1042/bcj20170942
|View full text |Cite
|
Sign up to set email alerts
|

Identification of a Wells–Dawson polyoxometalate-based AP-2γ inhibitor with pro-apoptotic activity

Abstract: AP-2 gamma (AP-2γ) is a transcription factor that plays pivotal roles in breast cancer biology. To search for small molecule inhibitors of AP-2γ, we performed a high-throughput fluorescence anisotropy screen and identified a polyoxometalate compound with Wells-Dawson structure K[PMoO] (Dawson-POM) that blocks the DNA-binding activity of AP-2γ. We showed that this blocking activity is due to the direct binding of Dawson-POM to AP-2γ. We also provided evidence to show that Dawson-POM decreases AP-2γ-dependent tr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
3
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 9 publications
(6 citation statements)
references
References 52 publications
1
3
0
Order By: Relevance
“…These findings confirm that AP-2α activity is influenced by tumor tissue type: while it was found to demonstrate oncogenic activity in cervical, gallbladder and ovarian cancer [27][28][29], it has been also seen to act as a suppressor in many other tumors [11,[30][31][32][33][34][35]. AP-2γ has been conclusively demonstrated to play an oncogenic role in breast cancer [36] (which coincides with previous evaluation) and furthermore expanded with its unfavorable characteristics in colorectal cancer [25]. The last representative of the AP-2 family abundantly described in the literature is beta member.…”
Section: Introductionsupporting
confidence: 64%
“…These findings confirm that AP-2α activity is influenced by tumor tissue type: while it was found to demonstrate oncogenic activity in cervical, gallbladder and ovarian cancer [27][28][29], it has been also seen to act as a suppressor in many other tumors [11,[30][31][32][33][34][35]. AP-2γ has been conclusively demonstrated to play an oncogenic role in breast cancer [36] (which coincides with previous evaluation) and furthermore expanded with its unfavorable characteristics in colorectal cancer [25]. The last representative of the AP-2 family abundantly described in the literature is beta member.…”
Section: Introductionsupporting
confidence: 64%
“…κ-carrageenan and glycerol were obtained from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China) Polyoxometalate (K 6 [Mo 18 O 62 P]) were synthesized according to the previous literature [ 25 ]. Escherichia coli ( E. coli ) and Staphylococcus aureusin ( S. aureus ) were purchased from China of Industrial Culture Collection (Beijing, China).…”
Section: Methodsmentioning
confidence: 99%
“…Recently, we examined the role of WWOX in conjunction with two interacting proteins, which together orchestrated biological processes diversely in BLCA depending on their cellular level [8]. These were two Activating Enhancer-Binding Protein 2 (AP-2) Transcription Factors (TFs), AP-2α and AP-2γ, members of the AP-2 family, whose natural function is related to early development regulation [9], but which are also involved in carcinogenesis [10][11][12][13][14], including BLCA [15][16][17]. AP-2α and AP-2γ have distinct roles in different tumors, and tend to play an anti-cancer or tumor-promoting role, respectively [9].…”
Section: Introductionmentioning
confidence: 99%